← hubDrugs

Aniracetam

Discover related

3 sources

← All substances
🔗 MergedComparePsychonautWikiTripSitPharmacology

Collated from PsychonautWiki, TripSit, Pharmacology. Where sources differ (e.g. dosing), Compare shows them side by side.

Sections

Also known as AniracetamPW

An anxiolytic nootropic which modulates the AMPA receptor. Significantly more potent than racetam. May have positive effects on memory and cognition. Little recreational value. Sold in Europe as a prescription drug, but not approved by the FDA in the US.TS

Addiction potentialPW
non-addictive with a low potential for abuse
TolerancePW
full tolerance develops with prolonged and repeated use; half after 3 - 7 days; baseline after 1 - 2 weeks
Cross-tolerancePW
racetam, nootropic

Oral

Route dataPsychonautWiki

ThresholdLightCommonStrongHeavy
350 mg500–1200 mg1200–1800 mg1800–2400 mg2400 mg+
03000 mg
LightCommonStrongHeavy
Onset45–90 minutes
Total3–5 hours
OnsetCome-upPeakOffset

Dangerous interactionsPW

🧬 Receptor activityPH

TargetActionAffinitySource
GluA1Positive (Allosteric modulator)GTOPDB
GluA2Positive (Allosteric modulator)GTOPDB
GluA3Positive (Allosteric modulator)GTOPDB
GluA4Positive (Allosteric modulator)GTOPDB
‹ PrevPage 1 / 11–4 of 4Next ›

PharmacodynamicsPH

Aniracetam possesses a wide range of anxiolytic properties, which may be mediated by an interaction between cholinergic, dopaminergic and serotonergic systems.

Pharmacokinetics

Half-lifePH

1-2.5 hours

Plan when to take Aniracetam — see where onset, peak and comedown land on the clock

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.